Viracta Therapeutics Announces New Employment Inducement
SAN DIEGO, Aug. 18, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients…